The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing

被引:8
作者
Starlinger, J. [1 ]
Kaiser, G. [1 ]
Thomas, A. [1 ,2 ]
Sarahrudi, K. [1 ,3 ]
机构
[1] Med Univ Vienna, Gen Hosp Vienna, Dept Orthopaed & Trauma Surg, Vienna, Austria
[2] Med Univ Vienna, Gender Med Unit, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria
[3] Wiener Neustadt Reg & Hosp, Dept Trauma Surg, Wiener Neustadt, Austria
来源
BONE & JOINT RESEARCH | 2019年 / 8卷 / 07期
关键词
Osteoprotegerin; sRANKL; Fracture healing; Nonunion; BONE-MINERAL DENSITY; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; CIRCULATING OSTEOPROTEGERIN; SERUM OSTEOPROTEGERIN; AGE; TESTOSTERONE; ESTROGEN; SMOKING; OPG;
D O I
10.1302/2046-3758.87.BJR-2018-0116.R3
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Objectives The osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) balance is of the utmost importance in fracture healing. The aim of this study was therefore to investigate the impact of nonosteogenic factors on OPG and RANKL levels. Methods Serum obtained from 51 patients with long bone fractures was collected over 48 weeks. The OPG and serum sRANKL (soluble RANKL) concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Smoking habit, diabetes, and alcohol consumption were recorded. Results Age and sex greatly influenced preoperative serum levels of OPG and sRANKL but differences were even more pronounced during fracture healing. Statistical significance was observed for overall serum levels of OPG (p = 0.001) and sRANKL (p < 0.001) in older men and women (age greater than 50 years). Interestingly, OPG levels increased over time in older women but decreased over time in older men. Conclusion These data suggest that nonosteogenic factors, most significantly age and sex, have a major impact on sRANKL and OPG levels. Given the established association of OPG and sRANKL levels and nonunion, these findings seem to be of clinical relevance.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 35 条
  • [21] Soluble receptor activator of nuclear factor-κB ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases
    Pulsatelli, L
    Dolzani, P
    Silvestri, T
    Caraceni, P
    Facchini, A
    Ravaglia, G
    Salvarani, C
    Meliconi, R
    Mariani, E
    [J]. BIOGERONTOLOGY, 2004, 5 (02) : 119 - 127
  • [22] Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study
    Rakic, V
    Davis, WA
    Chubb, SAP
    Islam, FMA
    Prince, RL
    Davis, TME
    [J]. DIABETOLOGIA, 2006, 49 (05) : 863 - 871
  • [23] REVIEW:: Circulating osteoprotegerin and receptor activator for nuclear factor κB ligand:: Clinical utility in metabolic bone disease assessment
    Rogers, A
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) : 6323 - 6331
  • [24] Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women
    Rogers, A
    Saleh, G
    Hannon, RA
    Greenfield, D
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) : 4470 - 4475
  • [25] Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol
    Santori, C.
    Ceccanti, M.
    Diacinti, D.
    Attilia, M. L.
    Toppo, L.
    D'Erasmo, E.
    Romagnoli, E.
    Mascia, M. L.
    Cipriani, C.
    Prastaro, A.
    Carnevale, V.
    Minisola, S.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (04) : 321 - 326
  • [26] Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing
    Sarahrudi, Kambiz
    Thomas, Anita
    Mousavi, Mehdi
    Kaiser, Georg
    Koettstorfer, Julia
    Kecht, Mathias
    Hajdu, S.
    Aharinejad, S.
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2011, 42 (08): : 833 - 837
  • [27] Osteoclastic activity begins early and increases over the course of bone healing
    Schell, H
    Lienau, J
    Epari, DR
    Seebeck, P
    Exner, C
    Muchow, S
    Bragulla, H
    Haas, NP
    Duda, GN
    [J]. BONE, 2006, 38 (04) : 547 - 554
  • [28] The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor κB legend with bone mineral density in older adults:: the Rancho Bernardo Study
    Stern, Anna
    Laughlin, Gail A.
    Bergstrom, Jaclyn
    Barrett-Connor, Elizabeth
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) : 555 - 562
  • [29] Osteoprotegerin serum levels in men: Correlation with age, estrogen, and testosterone status
    Szulc, P
    Hofbauer, LC
    Heufelder, AE
    Roth, S
    Delmas, PD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) : 3162 - 3165
  • [30] Effect of smoking on concentrations of receptor activator of nuclear factor κ B ligand and osteoprotegerin in human gingival crevicular fluid
    Tang, Teck H.
    Fitzsimmons, Tracy R.
    Bartold, P. Mark
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2009, 36 (09) : 713 - 718